avelumab
SpainDrugs containing this active substance
-
It is used in adults to treat three types of cancer: metastatic Merkel cell carcinoma (a rare type of skin cancer), advanced or metastatic urothelial carcinoma (urinary tract cancer), and advanced renal cell carcinoma (kidney cancer). In the case of kidney cancer, it must be used in conjunction with axitinib.
Form: solution for infusion, concentrate
Active substance Dosage avelumab 200 mg mg Manufacturer: Merck Europe B.V.